Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PULSE BIOSCIENCES, INC. Director's Dealing 2017

Apr 28, 2017

32093_dirs_2017-04-27_94a48f31-4a55-499c-8dad-ae8a979b3dbd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2017-04-25

Reporting Person: DUGGAN ROBERT W (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-04-25 Common Stock P 25187 $24.938 Acquired 2923379 Direct
2017-04-26 Common Stock P 10000 $24.469 Acquired 2933379 Direct
2017-04-27 Common Stock P 200 $22.95 Acquired 2933579 Direct

Footnotes

F1: This is the weighted average purchase price of the shares, which ranged from $24.841 to $24.978 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.

F2: This is the weighted average purchase price of the shares, which ranged from $24.45 to $24.47 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.